Bioventix benefits from antibody demand

Monoclonal antibodies are lab-made proteins that bind themselves to specific targets in the human body. They can be used in the detection and treatment of cancer, as well as a number of other diseases. Aim-traded Bioventix (BVXP) produces these antibodies in sheep and supplies them to customers in the field of clinical diagnostics.